Hsien-Hsien Lei reports that three companies, Neuromark, Psynomics, and SureGene, are now offering genetic tests for mental illness variants. Neuromark’s Mark-C test will test for markers GRIK2 and GRIA3, which are believed to increase the risk of suicidal thoughts in people on Celexa. Psynome tests for two mutations in the GRK3 gene associated with bipolar disorder. SureGene's AssureGene test will look at genes associated with patients at risk of developing psychosis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.